磁刺激
随机对照试验
萧条(经济学)
深部经颅磁刺激
背外侧前额叶皮质
物理医学与康复
前额叶皮质
医学
物理疗法
评定量表
心理学
脑刺激
执行职能
刺激
认知
听力学
蒙哥马利-奥斯伯格抑郁评定量表
重性抑郁障碍
试点试验
睡眠剥夺对认知功能的影响
汉密尔顿抑郁量表
精神科
神经心理学
工作记忆
作者
Véronique Desbeaumes Jodoin,Emma Bousseau,François Trottier-Duclos,Didier Jutras‐Aswad,François Lespérance,Elie Bou Assi,Dang Khoa Nguyen,Daniel M. Blumberger,Travis E. Baker,Martijn Arns,Zafiris Jeff Daskalakis,Paul Lespérance,Jean‐Philippe Miron
标识
DOI:10.64898/2026.03.13.26348335
摘要
ABSTRACT Background Intermittent theta burst stimulation (iTBS) and H-coil repetitive transcranial magnetic stimulation (rTMS) are FDA-cleared treatments for major depression; yet their comparative effectiveness in treatment-resistant depression (TRD) has not been evaluated in randomized trials. This pilot randomized trial was designed to obtain preliminary comparative estimates and to explore whether baseline cognitive functioning relates to early remission. Methods Twenty-eight adults with TRD were randomized to six weeks of iTBS delivered to the dorsolateral prefrontal cortex (DLPFC) using a figure-8 coil (n=15) or H-coil rTMS delivered to the dorsomedial prefrontal cortex (DMPFC) using a H7-coil (n=13). The primary outcome was change in 17-item Hamilton Depression Rating Scale (HRSD-17) score from baseline to week 6, analyzed with ANCOVA. Additional outcomes included response, remission, and symptom trajectories through week 18. Exploratory analyses examined the association between baseline cognitive functioning, such as executive functions and memory, and remission. Results Twenty-five participants completed all 30 sessions. Adjusted week-6 HRSD-17 scores did not differ between groups (mean difference −0.40, 95% CI −5.23 to 4.43; p=.865). Response rates were 40.0% for iTBS and 50.0% for H-coil (p>.60), and remission rates were identical across groups (20.0%). Remitters showed higher baseline executive functioning than non-remitters in exploratory analyses, although these associations were not confirmed in adjusted models. Conclusion In this pilot trial, iTBS and H7-coil rTMS showed symptom improvement, with no clear between-group pattern. Exploratory findings suggest a potential signal involving executive functioning that warrants further investigation. These results inform the feasibility and design of larger comparative trials. Trial registration ClinicalTrials.gov ( NCT05902312 )
科研通智能强力驱动
Strongly Powered by AbleSci AI